- Home
- MRNA vs WES Comparison
MRNA vs WES Comparison
Compare MRNA & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- WES
- Stock Information
- Founded
- MRNA 2010
- WES 2007
- Country
- MRNA United States
- WES United States
- Employees
- MRNA N/A
- WES N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- WES Natural Gas Distribution
- Sector
- MRNA Health Care
- WES Utilities
- Exchange
- MRNA Nasdaq
- WES Nasdaq
- Market Cap
- MRNA 13.4B
- WES 15.0B
- IPO Year
- MRNA 2018
- WES 2008
- Fundamental
- Price
- MRNA $28.02
- WES $38.46
- Analyst Decision
- MRNA Hold
- WES Hold
- Analyst Count
- MRNA 20
- WES 5
- Target Price
- MRNA $46.24
- WES $40.40
- AVG Volume (30 Days)
- MRNA 8.6M
- WES 1.3M
- Earning Date
- MRNA 08-01-2025
- WES 08-06-2025
- Dividend Yield
- MRNA N/A
- WES 9.47%
- EPS Growth
- MRNA N/A
- WES N/A
- EPS
- MRNA N/A
- WES 3.25
- Revenue
- MRNA $3,078,000,000.00
- WES $3,671,303,000.00
- Revenue This Year
- MRNA N/A
- WES $5.87
- Revenue Next Year
- MRNA $10.04
- WES $3.90
- P/E Ratio
- MRNA N/A
- WES $11.83
- Revenue Growth
- MRNA N/A
- WES 7.11
- 52 Week Low
- MRNA $23.15
- WES $33.60
- 52 Week High
- MRNA $91.99
- WES $43.33
- Technical
- Relative Strength Index (RSI)
- MRNA 46.33
- WES 43.87
- Support Level
- MRNA $25.30
- WES $37.50
- Resistance Level
- MRNA $27.08
- WES $38.95
- Average True Range (ATR)
- MRNA 1.33
- WES 0.91
- MACD
- MRNA -0.31
- WES -0.22
- Stochastic Oscillator
- MRNA 32.38
- WES 24.55
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.